Topical issues in combined oral contraceptives usage-Reference-Cited by-同舟云学术

Topical issues in combined oral contraceptives usage

Published:2018-04-15 Issue:2 Volume:20 Page:60-63
ISSN:2079-5831
Container-title:Gynecology
language:
Short-container-title:Gynecol.

Author:

Dubrovina S O

Abstract

The article presents topical issues of combined oral contraceptive (COC) use: among women with obesity, the effectiveness of COC in the management of premenstrual syndrome, the risk of thrombosis among women using of COCs and the economic justification for screening thrombophilia before the appointment of combined oral contraceptives, and the "quick start" of COCs after emergency contraception.

Publisher

Consilium Medicum

Subject

Obstetrics and Gynecology

Link

https://gynecology.orscience.ru/2079-5831/article/viewFile/30082/pdf

Reference35 articles.

1. Rocha A.L.L, Campos R.R, Miranda M.M.S et al. Safety of hormonal contraception for obese women. Expert Opin Drug Saf 2017; 16 (12): 1387-93.

2. Coney P, Washenik K, Langley R.G et al. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 2001; 63: 297-302.

3. Redmond G, Godwin A.J, Olson W, Lippman J.S. Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence. Contraception 1999; 60: 81-5.

4. Gallo M.F, Lopez L.M, Grimes D.A et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2011; 9: CD003987.

5. Oelkers W, Helmerhorst F.M, Wuttke W, Heithecker R. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers. Gynecol Endocrinol 2000; 14: 204-13.